Drug intelligence / Profile preview

m-sarcolysine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

m-sarcolysine is an alkylating agent with antineoplastic (anticancer) activity. It is a nitrogen mustard derivative structurally related to melphalan and is known as the para-isomer of melphalan (“sarcolysin” typically refers to the meta-isomer, m-sarcolysine)[1][3]. Like other alkylating agents, m-sarcolysine exerts its cytotoxic effect by crosslinking DNA strands, thereby inhibiting DNA replication and cellular proliferation, ultimately leading to cell death[1][3]. The agent has been explored both as a free drug and as part of peptide-drug conjugates for improved uptake and efficacy in cancer cells[3]. It has shown activity in preclinical and clinical studies involving hematological malignancies such as chronic lymphocytic leukemia. m-Sarcolysine is distinct from L-sarcolysin (melphalan) in its mechanism and pharmacokinetic profile, notably lacking cross-resistance to melphalan in certain cell types[3].

Other names
m-sarcolysine
02

Targets

DNA

Beyond the preview

Go deeper on m-sarcolysine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on m-sarcolysine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call